By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Multi User License - $2,500
Coming soon
Medical equipment is crucial for the diagnosis and treatment of many diseases, especially in the fields of radiography, critical care, and surgery.
Any instrument, apparatus, machine, appliance, implant, reagent for in vitro usage, software, substance, or related item utilised for a particular medical purpose is referred to as a medical device.
The majority of medical gadgets currently on the market were not designed for the demands and resources frequently found in many African countries, but rather for the needs and resources of high-income nations.
In order to increase African patients’ access to healthcare, it is vital to develop medical devices that are specifically made to solve these issues.
The Africa Medical Devices Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.
One of the earliest success stories in African health tech is Wisepill, which was founded in 2007. A storage container that notifies users when they forget to take their medication has been invented by a South African business.
When a pill is consumed, it also lets doctors or researchers know. It was demonstrated by numerous research conducted in South Africa and Uganda that Wisepill increased medication regimen adherence rates.
Medical services for diagnostics and preventive care should be easily available, according to Nigerian diagnostic company MDaaS Global. The firm has closed a seed extension investment to scale across Nigeria and today announced the launch of its product SentinelX. MDaaS, or medical devices as a service, is an acronym.
It has a nationwide network of technologically advanced diagnostic centres in Nigeria. A variety of services are provided by MDaaS diagnostic facilities. There are cardiac services like ECG and echo, as well as imaging services like digital x-ray and ultrasound. Then there are the lab services, which include haematological, immunoassay, and chemistry analysis.
The WHO Director-General and European Commissioner for International Partnerships met in Geneva to discuss the EU-WHO collaboration in global health and the ongoing efforts to reach a worldwide agreement on pandemic prevention, preparedness, and response.
A letter of intent was signed by the two senior representatives of the partner organizations to encourage local production of and access to drugs, vaccines, and medical equipment in Sub-Saharan Africa.
By promoting regulatory convergence across the continent, fostering technology transfer and the development of local production capacity, and enhancing the consolidation of demand and strategic purchasing of such products, the new initiative aims to empower African countries and partners, including the African Union, to further enable local manufacturing of medical products and health technologies.
